Citadel Advisors »

Gt Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 40k 0.59
2025-03-31 $45k 20k 2.24

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Gt Biopharma

DRW Holdings
Bank Of Montreal
Citadel Advisors
Geode Capital Management
Two Sigma Securities
Vanguard Group
Wells Fargo & Company
BlackRock
Advisor Group Holdings
Morgan Stanley
Newbridge Financial Services Group
UBS Group
Tower Research Capital
Hartland & Co
Jones Financial Companies, L.L

View all funds holding Gt Biopharma